Recruiting RSV Studies in Palo Alto
About RSV Clinical Trials in Palo Alto
Respiratory syncytial virus (RSV) is a common respiratory virus that usually causes mild, cold-like symptoms but can be serious in infants, older adults, and immunocompromised individuals. New preventive therapies including monoclonal antibodies and vaccines have recently been approved. Clinical trials continue to investigate improved treatments.
There are currently 1 rsv clinical trials recruiting participants in Palo Alto, CA. These studies are seeking a combined 550 participants. Research is being sponsored by Pfizer. Clinical trial participation is free and participants receive study-related medical care at no cost.
RSV Clinical Trials in Palo Alto — FAQ
Are there rsv clinical trials in Palo Alto?
Yes, there are 1 rsv clinical trials currently recruiting in Palo Alto, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Palo Alto?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you about next steps.
Are clinical trials in Palo Alto free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Palo Alto studies also compensate for your time and travel.
What rsv treatments are being tested?
The 1 active trials in Palo Alto are testing new therapies including novel drugs, biologics, and treatment approaches for rsv.
Data updated October 12, 2026 from ClinicalTrials.gov